Cargando…

An RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin

INTRODUCTION: The aim of this study was to confirm the efficacy of patient-driven titration of BIAsp 30 in terms of glycemic control, by comparing it to physician-driven titration of BIAsp 30, in patients with type 2 diabetes in North Africa, the Middle East, and Asia. METHODS: A 20-week, open-label...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chraibi, Abdelmjid, Al-Herz, Shoorook, Nguyen, Bich Dao, Soeatmadji, Djoko W., Shinde, Anil, Lakshmivenkataraman, Balasubramanian, Assaad-Khalil, Samir H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544605/ https://www.ncbi.nlm.nih.gov/pubmed/28523482 http://dx.doi.org/10.1007/s13300-017-0268-1

Ejemplares similares

Erratum to: An RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin
por: Chraibi, Abdelmjid, et al.
Publicado: (2017)

Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement
por: Brito, Miguel, et al.
Publicado: (2011)

Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis
por: Guo, Lixin, et al.
Publicado: (2021)

Clinical experience with insulin detemir type 2 diabetes mellitus, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Rabat-Sale-Zemmour-Zaer Region cohort of the A(1)chieve study
por: Chraibi, Abdelmjid, et al.
Publicado: (2013)

A commentary on the “consensus statement” regarding the use of BIAsp30
por: Kawamori, Ryuzo
Publicado: (2010)

CCNO mutations in NPH?
por: Núnez-Ollé, Marc, et al.
Publicado: (2018)

Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement
por: Unnikrishnan, A G, et al.
Publicado: (2009)

iNPH—the mystery resolving
por: Leinonen, Ville, et al.
Publicado: (2021)

Reducing IRS-1 Activation Cause Mutation of Tyrosine Kinase Domain hINSR Gene on Type-2 Diabetes Mellitus Patients
por: Fatchiyah, Fatchiyah, et al.
Publicado: (2013)

Comorbidites in NPH - local introspective - ‘Shunt them all’!
por: Haylock-Vize, Patricia Anne, et al.
Publicado: (2015)

Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes
por: Sherrill, Christina H., et al.
Publicado: (2020)

Efficacy of Insulin Titration Driven by SMS in Improving Glycemic Control in People with Type 2 Diabetes
por: Ortiz-Zúñiga, Ángel, et al.
Publicado: (2023)

Syndrome de régression embryonnaire des testicules: à propos de 6 cas
por: Latrech, Hanane, et al.
Publicado: (2014)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
por: Valensi, Paul
Publicado: (2009)

A new electronic valve for the treatment of NPH
por: Miethke, Christoph, et al.
Publicado: (2015)

There is more to NPH than lower body Parkinsonism
por: Oertel, Joachim M. K., et al.
Publicado: (2021)

The Clinical Utility of the MOCA in iNPH Assessment
por: Wesner, Eric, et al.
Publicado: (2022)

Update on the Cognitive Presentations of iNPH for Clinicians
por: Langheinrich, Tobias, et al.
Publicado: (2022)

NPH: are we giving up on patients with temporary improvement post shunt?
por: Thompson, Simon, et al.
Publicado: (2015)

Methyl glyoxal increase apoptosis (CASPASE-3 expression) in pre-osteoblast MC3T3E1 cell line via SOD activity
por: Akbar, Izaak Zoelkarnain, et al.
Publicado: (2012)

Disorder of Sexual Development and Congenital Heart Defect in 47XYY: Clinical Disorder or Coincidence?
por: Latrech, Hanane, et al.
Publicado: (2015)

Subject‐driven titration of biphasic insulin aspart 30 twice daily is non‐inferior to investigator‐driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open‐label, parallel‐group, multicenter trial
por: Yang, Wenying, et al.
Publicado: (2015)

GLYNAC SUPPLEMENTATION IN OLDER ADULTS PROTECTS FROM MEAL DRIVEN OXIDATIVE STRESS AND INFLAMMATION: RESULTS OF A RCT
por: Sekhar, Rajagopal, et al.
Publicado: (2022)

Barriers and Facilitators to the Implementation of a Mobile Insulin Titration Intervention for Patients With Uncontrolled Diabetes: A Qualitative Analysis
por: Rogers, Erin, et al.
Publicado: (2019)

Effect of Hyperglycemia to The mRNA Level and Protein Expression of Perlecan at Rat Model of Osteoarthritis with Diabetes Mellitus Type 1
por: Njoto, Ibrahim, et al.
Publicado: (2019)

Arterial hypertension and type 2 diabetes are frequent in iNPH
por: Pyykkö, Okko T, et al.
Publicado: (2015)

Surgical indication of iNPH (idiopathic normal pressure hydrocephalus)
por: Kimura, Teruo, et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics
por: Home, Philip D., et al.
Publicado: (2022)

DFT and molecular dynamics studies of astaxanthin-metal ions (Cu(2+) and Zn(2+)) complex to prevent glycated human serum albumin from possible unfolding
por: Wibowo, Syahputra, et al.
Publicado: (2021)

Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
por: Bae, Jae Hyun, et al.
Publicado: (2022)

Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
por: Lau, E., et al.
Publicado: (2019)

Ambulatory intracranial pressure monitoring in NPH with a miniaturized acquisition chain
por: Manet, Romain, et al.
Publicado: (2015)

Neuropsychological effects of shunting in iNPH – determining major and minor responses
por: Wallin, Maria, et al.
Publicado: (2015)

Study of a New Modified Insulin (Type N.P.H.)
por: Mukherjee, Surath Kumar
Publicado: (1952)

Particular CSF sphingolipid patterns identify iNPH and AD patients
por: Torretta, Enrica, et al.
Publicado: (2018)

Diagnostic accuracy of the iNPH Radscale in idiopathic normal pressure hydrocephalus
por: Kockum, Karin, et al.
Publicado: (2020)

Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco)
por: Haimeur, Adil, et al.
Publicado: (2013)

Clinicodemographic Profile and Outcomes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study
por: Soeatmadji, Djoko Wahono, et al.
Publicado: (2023)

Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study
por: Kamenov, Zdravko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6dn3si1hsbonvj63c1rmngeotk